Vaxcyte (PCVX) Capital Expenditures (2019 - 2026)
Vaxcyte (PCVX) recorded Capital Expenditures of $4.32 million in Q2 2026, up 138.5% from $1.81 million a year earlier and up 105.0% from the prior quarter.
Powered by 
Analysis
Vaxcyte (PCVX) Capital Expenditures (2019 - 2026) Analysis & Trends
On a TTM basis, Vaxcyte's Capital Expenditures came in at $12.9 million as of Jun 30, 2026, down 20.4% year-over-year; for FY2025, it was $13.71 million, down 38.9% from FY2024.
- Annual Capital Expenditures has a five-year compound annual growth rate of 64.0% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $22.43 million in FY2024 (+39.6%), $16.06 million in FY2023 (+175.0%), $5.84 million in FY2022 (-10.9%) and $6.56 million in FY2021 (+467.5%).
- The Q2 2026 figure is the highest quarterly Capital Expenditures since Q1 2025.
- On a year-over-year basis, Capital Expenditures rose in 1 of the last eight quarters, with an average decline of 14.6%.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 770.6% in Q3 2023, against a decline of 76.7% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.11 million (Q1 2026), $2.65 million (Q4 2025) and $3.82 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Vaxcyte | 8.44 Bn | 8.44 Bn | - | 4.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.32 Mn |
| Mar 31, 2026 | 2.11 Mn |
| Dec 31, 2025 | 2.65 Mn |
| Sep 30, 2025 | 3.82 Mn |
| Jun 30, 2025 | 1.81 Mn |
| Mar 31, 2025 | 5.42 Mn |
| Dec 31, 2024 | 4.02 Mn |
| Sep 30, 2024 | 4.95 Mn |
| Jun 30, 2024 | 7.78 Mn |
| Mar 31, 2024 | 5.68 Mn |
| Dec 31, 2023 | 5.25 Mn |
| Sep 30, 2023 | 7.34 Mn |
| Jun 30, 2023 | -2.14 Mn |
| Mar 31, 2023 | 5.61 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 843,000.00 |
| Jun 30, 2022 | 938,000.00 |
| Mar 31, 2022 | 2.92 Mn |
| Dec 31, 2021 | 1.38 Mn |
| Sep 30, 2021 | 1.72 Mn |
API Access
Vaxcyte Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();